Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 25Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 3Breast 2CNS 1

Conditions

Neoplasms 5Breast Neoplasms 5Brain Neoplasms 2Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Neoplasms × Lapatinib × Clear all
NCT07416409 2026-02-18

Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer

Deraya University

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT01332396 2017-04-26

Drug Use Investigation for TYKERB Tablet (All Case Investigation)

Novartis

Completed
4,054 enrolled
Tumor-Agnostic

Neoplasms

NCT00975988 2014-10-27

Regulatory TYKERB® Tablets PMS

GlaxoSmithKline

Completed
750 enrolled
Tumor-Agnostic

Neoplasms

NCT01077648 2014-05-26

Brain Metastasis in Breast Cancer Patients

GlaxoSmithKline

Completed
1 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡